E-LIB Suche - Ergebnisse für: Luhn, Kerstin

1

Safety and Immunogenicity of Accelerated Heterologous Two-d..:

Mwesigwa, Betty ; Sawe, Fredrick ; Oyieko, Janet...
Clinical Infectious Diseases. , 2024

Link: https://doi.org/10.1093/..

2

Long-Term Clinical Safety of the Ad26.ZEBOV and MVA-BN-Filo..:

Puri, Adeep ; Pollard, Andrew J. ; Schmidt-Mutter, Catherine...
Vaccines. 12 (2024) 2 - p. 210 , 2024

Link: https://doi.org/10.3390/..

3

Safety and Immunogenicity of an Accelerated Ebola Vaccinati..:

Ake, Julie A. ; Paolino, Kristopher ; Hutter, Jack N....
Vaccines. 12 (2024) 5 - p. 497 , 2024

Link: https://doi.org/10.3390/..

4

Lot-to-lot consistency, immunogenicity, and safety of the A..:

Goldstein, Neil ; McLean, Chelsea ; Gaddah, Auguste...
Human Vaccines & Immunotherapeutics. 20 (2024) 1 - p. , 2024

Link: https://doi.org/10.1080/..

5

Immune response of a two-dose heterologous Ebola vaccine re..:

McLean, Chelsea ; Barry, Houreratou ; Kieh, Mark...
eBioMedicine. 91 (2023) - p. 104562 , 2023

Link: https://doi.org/10.1016/..

6

Persistence of immunological memory as a potential correlat..:

McLean, Chelsea ; Dijkman, Karin ; Gaddah, Auguste...
Frontiers in Immunology. 14 (2023) - p. , 2023

Link: https://doi.org/10.3389/..

7

Safety and immunogenicity of an Ad26.ZEBOV booster vaccine ..:

Man-Lik Choi, Edward ; Abu-Baker Mustapher, Ggayi ; Omosa-Manyonyi, Gloria...
Vaccine. 41 (2023) 50 - p. 7573-7580 , 2023

Link: https://doi.org/10.1016/..

8

Identification of early gene expression profiles associated..:

Blengio, Fabiola ; Hocini, Hakim ; Richert, Laura...
Cell Reports. 42 (2023) 9 - p. 113101 , 2023

Link: https://doi.org/10.1016/..

9

Safety and immunogenicity of an Ad26.ZEBOV booster dose in ..:

Manno, Daniela ; Bangura, Agnes ; Baiden, Frank...
The Lancet Infectious Diseases. 23 (2023) 3 - p. 352-360 , 2023

Link: https://doi.org/10.1016/..

10

First-in-human study to evaluate safety, tolerability, and ..:

Bockstal, Viki ; Shukarev, Georgi ; McLean, Chelsea...
PLOS ONE. 17 (2022) 10 - p. e0274906 , 2022

Link: https://doi.org/10.1371/..

11

An introduction to the Marburg virus vaccine consortium, MA..:

Cross, Robert W. ; Longini, Ira M. ; Becker, Stephan...
PLOS Pathogens. 18 (2022) 10 - p. e1010805 , 2022

Link: https://doi.org/10.1371/..

12

NK Cell Subset Redistribution and Antibody Dependent Activa..:

Wagstaffe, Helen R. ; Anzala, Omu ; Kibuuka, Hannah...
Vaccines. 10 (2022) 6 - p. 884 , 2022

Link: https://doi.org/10.3390/..

13

Non-human primate to human immunobridging demonstrates a pr..:

Bockstal, Viki ; Leyssen, Maarten ; Heerwegh, Dirk...
npj Vaccines. 7 (2022) 1 - p. , 2022

Link: https://doi.org/10.1038/..

14

Protection against Marburg Virus and Sudan Virus in NHP by ..:

Tiemessen, Machteld M. ; Solforosi, Laura ; Dekking, Liesbeth...
Vaccines. 10 (2022) 8 - p. 1263 , 2022

Link: https://doi.org/10.3390/..

15

Protocol for a phase 3 trial to evaluate the effectiveness ..:

Watson-Jones, Deborah ; Kavunga-Membo, Hugo ; Grais, Rebecca F...
BMJ Open. 12 (2022) 3 - p. e055596 , 2022

Link: https://doi.org/10.1136/..